Monogenic diabetes

Gene: SLC19A2

Amber List (moderate evidence)

SLC19A2 (solute carrier family 19 member 2)
EnsemblGeneIds (GRCh38): ENSG00000117479
EnsemblGeneIds (GRCh37): ENSG00000117479
OMIM: 603941, Gene2Phenotype
SLC19A2 is in 16 panels

5 reviews

Ida Ertmanska (Genomics England Curator)

Green List (high evidence)

Comment on list classification: As reviewed by Kevin Colclough, patients with biallelic SLC19A2 variants are often diagnosed with diabetes after 9 months of age, which is in scope of this panel. Hence, SLC19A2 should be promoted to Green for Monogenic diabetes at the next update, with MOI set to BIALLELIC, autosomal or pseudoautosomal.
Created: 27 Mar 2026, 11:15 a.m. | Last Modified: 27 Mar 2026, 11:15 a.m.
Panel Version: 3.15

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Thiamine-responsive megaloblastic anemia syndrome, OMIM:249270; diabetes mellitus, MONDO:0005015

Kevin Colclough (Royal Devon & Exeter NHS Healthcare Trust)

Green List (high evidence)

Biallelic pathogenic variants in SLC19A2 cause diabetes, thiamine responsive megaloblastic anaemia and sensorineural deafness (PMID: 20301459) and the gene is included as a green gene on the R143 neonatal diabetes panel as patients can present in the neonatal period. Patients can also be diagnosed in childhood. A literature review of 166 patients with biallelic SLC19A2 variants reported a diabetes prevalence of 93% (140 cases), and about half were diagnosed after the age of 12 months (PMID: 33571483). The Exeter laboratory has identified 50 children with SLC19A2 diabetes diagnosed > 9 months ranging from 1 to 14 years at diabetes diagnosis, and these individuals would not be eligible for R143 testing since this is only available to patients diagnosed under the age of 9 months.
Created: 12 Mar 2026, 1:02 p.m. | Last Modified: 12 Mar 2026, 1:02 p.m.
Panel Version: 3.10

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Diabetes; megaloblastic anaemia; sensorineural hearing loss; optic atrophy

Publications

Variants in this GENE are reported as part of current diagnostic practice

Ivone Leong (Genomics England Curator)

Red List (low evidence)

Gene changed to grey status after consultation with Professor Sian Ellard (South West GLH) that this gene is not appropriate for the panel.
Created: 25 Jan 2019, 11:49 a.m.

Sian Ellard (University of Exeter Medical School)

Green List (high evidence)

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Variants in this GENE are reported as part of current diagnostic practice

Ellen McDonagh (Genomics England Curator)

Comment on list classification: Promoted from red to green due to expert review and additional evidence on OMIM and from literature search.
Created: 15 Jun 2016, 3:16 p.m.

History Filter Activity

27 Mar 2026, Gel status: 2

Set Phenotypes

Ida Ertmanska (Genomics England Curator)

Phenotypes for gene: SLC19A2 were changed from Thiamine-responsive megaloblastic anemia syndrome; MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUS AND SENSORINEURAL DEAFNESS ROGERS SYNDROME to Thiamine-responsive megaloblastic anemia syndrome, OMIM:249270; diabetes mellitus, MONDO:0005015

27 Mar 2026, Gel status: 2

Set publications

Ida Ertmanska (Genomics England Curator)

Publications for gene: SLC19A2 were set to 26549656; 26839896

27 Mar 2026, Gel status: 2

Removed Tag, Added Tag, Added Tag

Ida Ertmanska (Genomics England Curator)

Tag curated_removed was removed from gene: SLC19A2. Tag Q1_26_promote_green tag was added to gene: SLC19A2. Tag Q1_26_NHS_review tag was added to gene: SLC19A2.

27 Mar 2026, Gel status: 2

Entity classified by Genomics England curator

Ida Ertmanska (Genomics England Curator)

Gene: slc19a2 has been classified as Amber List (Moderate Evidence).

26 Feb 2021, Gel status: 0

Added Tag

Arina Puzriakova (Genomics England Curator)

Tag curated_removed tag was added to gene: SLC19A2.

30 Jan 2019, Gel status: 0

Panel promoted to version 1.0

Ivone Leong (Genomics England Curator)

Ivone Leong: Gene changed to grey status af

25 Jan 2019, Gel status: 0

Added New Source, Status Update

Ivone Leong (Genomics England Curator)

Source Expert Review Removed was added to SLC19A2. Rating Changed from Green List (high evidence) to No List (delete)

18 Dec 2018, Gel status: 4

Set Phenotypes, Set publications

Ellen McDonagh (Genomics England Curator)

Added phenotypes Thiamine-responsive megaloblastic anemia syndrome; MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUS AND SENSORINEURAL DEAFNESS ROGERS SYNDROME for gene: SLC19A2 Publications for gene SLC19A2 were changed from Shaw-Smith et al 2012 Pediatr Diabetes 13:314-321; 26839896; 26549656 to 26549656; 26839896

18 Dec 2018, Gel status: 4

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Ellen McDonagh (Genomics England Curator)

gene: SLC19A2 was added gene: SLC19A2 was added to Monogenic diabetes. Sources: Expert Review Green Mode of inheritance for gene: SLC19A2 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: SLC19A2 were set to Shaw-Smith et al 2012 Pediatr Diabetes 13:314-321; 26839896; 26549656 Phenotypes for gene: SLC19A2 were set to Thiamine-responsive megaloblastic anemia syndrome; MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUS AND SENSORINEURAL DEAFNESS ROGERS SYNDROME